background antiproteases including supposed prevent lungs emphysematous genetic susceptibility smoking injury confer risk development chronic obstructive pulmonary disease copd methods investigated association polymorphism aact antiproteases susceptibility development copd heavy smokers blood samples obtained patients copd n NUMBER control subjects n NUMBER tokyo university hospital juntendo university hospital tokyo kenbikyoin clinic used genotyping assay polymerase chain reaction pcr restriction fragment length polymorphism rflp performed genotype aact biallelic polymorphism signal peptide alanine threonine polymorphisms exon pro229ala leu55pro results proportion homozygotes significantly higher copd patients control subjects copd NUMBER vs control NUMBER odds ratio homozygotes vs genotypes NUMBER NUMBER ci copd group association polymorphisms copd conclusions genetic polymorphism signal peptide aact associated individual susceptibility development copd genotype predominantly patients copd suggested genotype protective smoking injury alpha NUMBER antitrypsin alpha NUMBER antichymotrypsin NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER aact ala aact ala aact ala aact ala